Ra Capital Management, L.P. - Jan 11, 2024 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director, 10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Stock symbol
SLDB
Transactions as of
Jan 11, 2024
Transactions value $
$5,000,005
Form type
4
Date filed
1/12/2024, 05:01 PM
Previous filing
Dec 13, 2023
Next filing
Feb 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLDB Common Stock Purchase $5M +904K +27.5% $5.53 4.19M Jan 11, 2024 See footnotes F1, F2, F4
holding SLDB Common Stock 110K Jan 11, 2024 See footnotes F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired from the Issuer pursuant to the Securities Purchase Agreement dated January 8, 2024
F2 Held directly by RA Capital Healthcare Fund, L.P. (the "Fund").
F3 Held directly by RA Capital Nexus Fund, L.P. (the "Nexus Fund").
F4 RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Nexus Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

Remarks:

Mr. Shah, a Managing Partner of the Adviser, serves on the Issuer's board of directors.